https://doi.org/10.55788/cecbdf3a
Verbal fluency often declines after bilateral STN-DBS in patients with PD. “The here presented result is very important because non-motor symptoms in PD are a very important factor for the quality of life,” said Dr Victor del Bene (University of Alabama, AL, USA), who presented the results [1]. He said bilateral STN-DBS is safe and has very positive patient-reported outcomes. However, a common adverse event is a cognitive change, including a decline in verbal fluency and memory. It is unknown if this holds for unilateral STN-DB. Therefore, Dr Del Bene and his group investigated verbal fluency following unilateral STN-DBS in a subcohort of the SUNDIAL trial (NCT03353688). The larger purpose of this randomised, double-blind crossover study is to measure the clinical efficacy of directional versus omnidirectional stimulation in PD and to explore whether electrophysiology biomarkers can rapidly predict effective, well-tolerated contacts for directional DBS therapy. Dr Del Bene and his group enrolled 31 SUNDIAL participants who underwent unilateral STN-DBS. The most symptomatic side was treated resulting in 17 participants treated on their left side and 14 on their right side. At baseline and at 2, 4, and 6 months after surgery, participants underwent verbal fluency and memory assessments and the Stroop test.
At baseline, none of the participants showed signs of cognitive impairment. Verbal fluency scores were significantly lower among participants after left-side STN-DBS (t(20.66)=-2.49; P=0.02). Over 6 months of follow-up, Dr Del Bene and colleagues observed a gradual further decline in verbal fluency in the left STN-DBS group by about 25% (P=0.02). This result was consistent with published data, according to Dr Del Bene. For participants with right-side STN-DBS, verbal fluency improved by about 25% (P<0.001). This group also showed significant improvements in the Stroop test by about 18%.
The results suggest that selecting unilateral right STN-DBS to control left-sided symptoms could reduce the likelihood of verbal fluency declines in patients with PD. Dr Del Bene concluded: “At the very least, there is no evidence of a decline in verbal fluency and response inhibition in the right-side DBS group.”
- Del Bene VA. Evidence of improved verbal fluency following unilateral right hemisphere subthalamic nucleus deep brain stimulation for Parkinson’s disease. S51.003, AAN 2023 Annual Meeting, 22–27 April, Boston, USA.
Copyright ©2023 Medicom Medical Publishers
Posted on
Previous Article
« First-ever ALS platform trial reports on outcomes of 4 treatments Next Article
Continuous levodopa/carbidopa infusion shows favourable safety and efficacy »
« First-ever ALS platform trial reports on outcomes of 4 treatments Next Article
Continuous levodopa/carbidopa infusion shows favourable safety and efficacy »
Table of Contents: AAN 2023
Featured articles
Letter from the Editor
Positive results for hereditary transthyretin-mediated amyloid polyneuropathy
Infectious Diseases
Allogenic T-cell-based immunotherapy for PML in development
Cognitive Impairment and Dementia
Lecanemab may slow decline of cognition and function in Alzheimer’s Disease
Donanemab shows rapid and deep plaque clearance in early Alzheimer’s Disease
Epilepsy
Seizure forecasting and detection with wearable devices are feasible
Encouraging first results of GABAergic interneurons implants for focal epilepsy
Headache and Migraine
Lecture on migraine: from the prodromal phase to future paradigm shifts
Zavegepant nasal spray exhibits good efficacy and safety in acute migraine
A vaccine as a potentially safe and effective immunotherapy against CGRP
Multiple Sclerosis
Teriflunomide prevents conversion to MS in patients with RIS
Gold nanocrystals may be effective as adjunctive MS therapy
Muscle and Neuro-Muscular Disorders
First-ever ALS platform trial reports on outcomes of 4 treatments
Pridopidine for Huntington’s disease fails to meet the primary endpoint
Parkinson's Disease
Continuous levodopa/carbidopa infusion shows favourable safety and efficacy
Unilateral right STN-DBS improves verbal fluency
Stroke
Harnessing the microbiome as a possible stroke treatment
Patients with a large core infarct benefit from thrombectomy
Miscellaneous
Artificial intelligence applications in neurology: seize the moment
Spinal cord stimulation eases painful diabetic neuropathy
EVT improves functional outcomes in Chinese patients with BAO
Severe sleep apnoea associated with white matter hyperintensities
Related Articles
October 30, 2022
In the spotlight: Cancer trends in obstructive sleep apnoea
July 5, 2021
OSA: A risk factor for earlier cognitive decline
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com